GRAVITAS-119: Phase I Study of Itacitinib Plus Calcineurin Inhibitors as Prophylaxis for GVHD

Dr. Corey S. Cutler shares his views on current and future graft-vs-host disease (GVHD) therapies in this commentary from Clinical Care Options (CCO)

Corey S. Cutler, MD, MPH, FRCPC Released: April 27, 2021

Interactive online tool providing expert management recommendations for β-thalassemia from Clinical Care Options (CCO)

Jeanne Boudreaux, MD Stephanie A. Fritch Lilla, MD Janet L. Kwiatkowski, MD, MSCE Sujit Sheth, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: April 22, 2021 Expired: April 21, 2022

On-demand Webcast updated with data from ASH 2020 with expert faculty discussing recent data on management of hemophilia A, presented by Clinical Care Options (CCO)

Miguel A. Escobar, MD
Program Director Michael Callaghan, MD Rebecca Kruse-Jarres, MD, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: February 25, 2021 Expired: February 24, 2022

Hanny Al-Samkari, MD; Sujit Sheth, MD; and Mark A. Schroeder, MD: top picks of nonmalignant hematology studies from ASH 2020 as reported by CCO

Hanny Al-Samkari, MD Mark A. Schroeder, MD Sujit Sheth, MD Released: February 24, 2021